859 related articles for article (PubMed ID: 25174529)
1. Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures.
Proctor DM; Suh M; Campleman SL; Thompson CM
Toxicology; 2014 Nov; 325():160-79. PubMed ID: 25174529
[TBL] [Abstract][Full Text] [Related]
2. Inhalation cancer risk assessment for environmental exposure to hexavalent chromium: Comparison of margin-of-exposure and linear extrapolation approaches.
Proctor DM; Bhat V; Suh M; Reichert H; Jiang X; Thompson CM
Regul Toxicol Pharmacol; 2021 Aug; 124():104969. PubMed ID: 34089813
[TBL] [Abstract][Full Text] [Related]
3. Human health risk and exposure assessment of chromium (VI) in tap water.
Paustenbach DJ; Finley BL; Mowat FS; Kerger BD
J Toxicol Environ Health A; 2003 Jul; 66(14):1295-339. PubMed ID: 12851114
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of the mode of action framework for mutagenic carcinogens case study II: chromium (VI).
McCarroll N; Keshava N; Chen J; Akerman G; Kligerman A; Rinde E
Environ Mol Mutagen; 2010 Mar; 51(2):89-111. PubMed ID: 19708067
[TBL] [Abstract][Full Text] [Related]
5. Workplace airborne hexavalent chromium concentrations for the Painesville, Ohio, chromate production plant (1943-1971).
Proctor DM; Panko JP; Liebig EW; Scott PK; Mundt KA; Buczynski MA; Barnhart RJ; Harris MA; Morgan RJ; Paustenbach DJ
Appl Occup Environ Hyg; 2003 Jun; 18(6):430-49. PubMed ID: 12746066
[TBL] [Abstract][Full Text] [Related]
6. Chromium VI and stomach cancer: a meta-analysis of the current epidemiological evidence.
Welling R; Beaumont JJ; Petersen SJ; Alexeeff GV; Steinmaus C
Occup Environ Med; 2015 Feb; 72(2):151-9. PubMed ID: 25231674
[TBL] [Abstract][Full Text] [Related]
7. Hexavalent chromium exposures and exposure-control technologies in American enterprise: results of a NIOSH field research study.
Blade LM; Yencken MS; Wallace ME; Catalano JD; Khan A; Topmiller JL; Shulman SA; Martinez A; Crouch KG; Bennett JS
J Occup Environ Hyg; 2007 Aug; 4(8):596-618. PubMed ID: 17577750
[TBL] [Abstract][Full Text] [Related]
8. Hexavalent Chromium (Cr(VI)) Down-Regulates Acetylation of Histone H4 at Lysine 16 through Induction of Stressor Protein Nupr1.
Chen D; Kluz T; Fang L; Zhang X; Sun H; Jin C; Costa M
PLoS One; 2016; 11(6):e0157317. PubMed ID: 27285315
[TBL] [Abstract][Full Text] [Related]
9. Is hexavalent chromium carcinogenic via ingestion? A weight-of-evidence review.
Proctor DM; Otani JM; Finley BL; Paustenbach DJ; Bland JA; Speizer N; Sargent EV
J Toxicol Environ Health A; 2002 May; 65(10):701-46. PubMed ID: 12028825
[TBL] [Abstract][Full Text] [Related]
10. The clastogenic effects of chronic exposure to particulate and soluble Cr(VI) in human lung cells.
Holmes AL; Wise SS; Sandwick SJ; Wise JP
Mutat Res; 2006 Nov; 610(1-2):8-13. PubMed ID: 16870495
[TBL] [Abstract][Full Text] [Related]
11. Assessment of genotoxic potential of Cr(VI) in the mouse duodenum: an in silico comparison with mutagenic and nonmutagenic carcinogens across tissues.
Thompson CM; Gregory Hixon J; Proctor DM; Haws LC; Suh M; Urban JD; Harris MA
Regul Toxicol Pharmacol; 2012 Oct; 64(1):68-76. PubMed ID: 22705708
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-mesenchymal transition during oncogenic transformation induced by hexavalent chromium involves reactive oxygen species-dependent mechanism in lung epithelial cells.
Ding SZ; Yang YX; Li XL; Michelli-Rivera A; Han SY; Wang L; Pratheeshkumar P; Wang X; Lu J; Yin YQ; Budhraja A; Hitron AJ
Toxicol Appl Pharmacol; 2013 May; 269(1):61-71. PubMed ID: 23518002
[TBL] [Abstract][Full Text] [Related]
13. Hexavalent chromium compounds in the workplace: assessing the extent and magnitude of occupational exposure in Italy.
Scarselli A; Binazzi A; Marzio DD; Marinaccio A; Iavicoli S
J Occup Environ Hyg; 2012; 9(6):398-407. PubMed ID: 22577838
[TBL] [Abstract][Full Text] [Related]
14. Chromium IV exposure, via Src/Ras signaling, promotes cell transformation.
Ganapathy S; Li P; Lafontant J; Xiong R; Yu T; Zhang G; Chen C
Mol Carcinog; 2017 Jul; 56(7):1808-1815. PubMed ID: 28218450
[TBL] [Abstract][Full Text] [Related]
15. Impact of hexavalent chromium on mammalian cell bioenergetics: phenotypic changes, molecular basis and potential relevance to chromate-induced lung cancer.
Abreu PL; Ferreira LM; Alpoim MC; Urbano AM
Biometals; 2014 Jun; 27(3):409-43. PubMed ID: 24664226
[TBL] [Abstract][Full Text] [Related]
16. Gene 33/Mig6 inhibits hexavalent chromium-induced DNA damage and cell transformation in human lung epithelial cells.
Park S; Li C; Zhao H; Darzynkiewicz Z; Xu D
Oncotarget; 2016 Feb; 7(8):8916-30. PubMed ID: 26760771
[TBL] [Abstract][Full Text] [Related]
17. Estimating historical occupational exposure to airborne hexavalent chromium in a chromate production plant: 1940--1972.
Proctor DM; Panko JP; Liebig EW; Paustenbach DJ
J Occup Environ Hyg; 2004 Nov; 1(11):752-67. PubMed ID: 15673096
[TBL] [Abstract][Full Text] [Related]
18. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
19. Development of a cancer-based chronic inhalation reference value for hexavalent chromium based on a nonlinear-threshold carcinogenic assessment.
Haney JT; Erraguntla N; Sielken RL; Valdez-Flores C
Regul Toxicol Pharmacol; 2012 Dec; 64(3):466-80. PubMed ID: 23103602
[TBL] [Abstract][Full Text] [Related]
20. Comparison of in vivo genotoxic and carcinogenic potency to augment mode of action analysis: Case study with hexavalent chromium.
Thompson CM; Bichteler A; Rager JE; Suh M; Proctor DM; Haws LC; Harris MA
Mutat Res Genet Toxicol Environ Mutagen; 2016 Apr; 800-801():28-34. PubMed ID: 27085472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
